PARALLELL PROGRAMME

PARALLELL PROGRAMME

Thursday March 9
Category: Parallel Session 3A: Business Arena – Company Spotlight
13:15

MSCi - The GC Company – Smart analysis of really complicated matrices 

Parallel Session 3A: Business Arena – Company Spotlight
Jens Glastrup, Owner (Denmark)
13:30

BioCHOS – Antifungal chitosan oligomers (CHOS)

Parallel Session 3A: Business Arena – Company Spotlight
Berit Bjugan Aam, CEO (Norway)
13:42

Catapult Life Science – Bridging the gap between research and market

Parallel Session 3A: Business Arena – Company Spotlight
Astrid Myrseth, CEO (Norway)
13:54

Njorth Bio_ – A platform for commercializing innovative bio-based ideas through a shared-resource solution

Parallel Session 3A: Business Arena – Company Spotlight
Jessica Green, Business Developer (Norway)
14:06

ArcticZymes – Enzyme innovations from the Arctic

Parallel Session 3A: Business Arena – Company Spotlight
Olav Lanes, Director of R&D and Applications (Norway)
14:18

Tailorzyme – Enzyme Solutions designed for customer substrates based on decades of industrial application experience

Parallel Session 3A: Business Arena – Company Spotlight
Lars Peter Andersen, CEO & Partner (Denmark)
15:00

NanoTemper Technologies – Biomolecular analytics using MicroScale Thermophoresis (MST) and nanoDSF

Parallel Session 3A: Business Arena – Company Spotlight
René Wink, Application Specialist (Germany)
15:12

BioMimetx - Disruptive antifouling components from bacteria

Parallel Session 3A: Business Arena – Company Spotlight
Gonçalo Costa, Co-founder & CSO (Portugal)
15:24

SINTEF Ocean – Norwegian Centre for Plankton Technology

Parallel Session 3A: Business Arena – Company Spotlight
Gunvor Øie, Research Director (Norway)
15:36

Nofima BioTep – Commercialization of research innovation – crossing the valley of death

Parallel Session 3A: Business Arena – Company Spotlight
Ragnhild Whitaker, Research Manager (Norway)
15:48

MARBIONC Development Group – Bringing University Discoveries and Products to the Market Place

Parallel Session 3A: Business Arena – Company Spotlight
Andrea Bourdelais, Research Associate Professor (USA)
16:00

The Life Science Cluster – Unleashing the potential of Norway’s life sciences sectors

Parallel Session 3A: Business Arena – Company Spotlight
Marius Øgaard, Managing Director (Norway)
16:12

Biocenter Oulo – Developing integrated disruptive biosensors

Parallel Session 3A: Business Arena – Company Spotlight
Seppo Vainio, Professor (Finland)
16:24

D’Liver – Cutting edge technology for liver clearance research

Parallel Session 3A: Business Arena – Company Spotlight
Kjetil Elvevold, Senior Scientist (Norway)
Category: Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development
13:15
Keynote Presentation: Synthetic biology - an important tool for industrial biotechnology
Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development
Trygve Brautaset, Professor
NTNU, Norway
13:45
New bioactive compounds from environmental microbial resources by an integrated functional (meta)genomics approach
Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development
Alexander Wentzel, Senior Researcher
SINTEF, Norway
14:15
High-throughput functional metagenomics for the discovery of glycan metabolic pathways
Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development
Gabrielle Potocki-Veronese, Research Director
INRA, France
15:05

Three oral poster presentations

Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development
Poster Presentors: Antonio García-Moyano, Anja Martinez, and Jenny Söderberg
15:20
The use of new targeted bioinformatics tools to streamline sequence-based target selection
Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development
Syed Asad Rahman; Bio/Chemo Informatician
EMBL-EBI, UK
15:50
Perspectives from the recombinant protein production industry
Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development
Trond Erik Vee Aune, Founder/CEO
Vectron Biosolutions, Norway
16:10
Enzyme development: From sequence to enzyme in 8 weeks
Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development
Stuart West, Managing Director
Biocatalysts, UK
16:30
End of Scientific Programme - Day 2
Parallel Session 3B: Synthetic biology – Enabling targeted and accelerated production organism development